• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Enlightify Inc.

    5/16/25 4:30:04 PM ET
    $ENFY
    Agricultural Chemicals
    Industrials
    Get the next $ENFY alert in real time by email
    NT 10-Q 1 ea024260301-nt10q_enlightify.htm NOTIFICATION OF LATE FILING

     

      

     

    UNITED STATES  

    SECURITIES AND EXCHANGE COMMISSION  

    Washington, D.C. 20549  

     

    FORM 12b-25  

     

    NOTIFICATION OF LATE FILING  

    OMB APPROVAL
      OMB Number: 3235-0058
      Expires: April 30, 2025
      Estimated average burden hours per response ... 2.50
       
      SEC FILE NUMBER
      001-34260
       
       
     

    CUSIP NUMBER

    16943W204

     

    (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR
       
      For Period Ended: March 31, 2025

      

      ☐ Transition Report on Form 10-K

     

      ☐ Transition Report on Form 20-F

     

      ☐ Transition Report on Form 11-K

     

      ☐ Transition Report on Form 10-Q

     

      ☐ Transition Report on Form N-SAR For the Transition Period Ended:

     

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I — REGISTRANT INFORMATION

     

    Enlightify, Inc.

    Full Name of Registrant

     

    Former Name if Applicable

     

    3rd Floor, Borough A, Block A. No. 181, South Taibai Road

    Address of Principal Executive Office (Street and Number)

     

    Xi’an, Shaanxi Province, PRC 710065

    City, State and Zip Code

     

     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

      (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
         
    ☒  (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
         
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III — NARRATIVE

     

    State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    The Company is unable to file this Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 within the prescribed time period without unreasonable effort or expense because additional time is required to complete the preparation of the Company’s financial statements in time for filing. This Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 will be filed as soon as practicable.

     

    PART IV — OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

      Zhuoyu Li   +86   29-88266368
      (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

     

    Yes ☒ No ☐

     

    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

     

    Yes ☐ No ☒

     

      If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2

     

     

    ENLIGHTIFY, INC.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

      

    Date: May 16, 2025 By: /s/ Zhuoyu Li
      Name:  Zhuoyu Li
      Title: Chief Executive Officer

     

    The statements included in this Form 12b-25 regarding our financial performance and results of operations, in each case as expected to be reported and other statements that are not historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Although we believe the expectations and estimates reflected in our forward-looking statements are reasonable, we can give no assurance they will prove to have been correct. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. Factors that could cause actual results to differ materially from expected results include the results and finalization of the Company’s financial statements, audit and reviews and those described under Risk Factors in our filings with the U.S. Securities and Exchange Commission.

     

    INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

     

     
    ATTENTION
     
    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
     

     

    GENERAL INSTRUCTIONS

     

    1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities Exchange Act of 1934.

     

    2. One signed original and four conformed copies of this form and amendments thereto must be completed and filed with the Securities and Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the General Rules and Regulations under the Act. The information contained in or filed with the form will be made a matter of public record in the Commission files.

     

    3. A manually signed copy of the form and amendments thereto shall be filed with each national securities exchange on which any class of securities of the registrant is registered.

     

    4. Amendments to the notifications must also be filed on Form 12b-25 but need not restate information that has been correctly furnished. The form shall be clearly identified as an amended notification.

     

    5. Interactive data submissions. This form shall not be used by electronic filers with respect to the submission or posting of an Interactive Data File (§232.11 of this chapter). Electronic filers unable to submit or post an Interactive Data File within the time period prescribed should comply with either Rule 201 or 202 of Regulation S-T (§232.201 and §232.202 of this chapter).

     

    3

     

     

     

     

     

    Get the next $ENFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ENFY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ENFY
    SEC Filings

    View All

    Enlightify Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Enlightify Inc. (0000857949) (Filer)

    1/9/26 5:00:45 PM ET
    $ENFY
    Agricultural Chemicals
    Industrials

    SEC Form DEF 14A filed by Enlightify Inc.

    DEF 14A - Enlightify Inc. (0000857949) (Filer)

    11/21/25 5:00:43 PM ET
    $ENFY
    Agricultural Chemicals
    Industrials

    SEC Form 10-Q filed by Enlightify Inc.

    10-Q - Enlightify Inc. (0000857949) (Filer)

    11/17/25 4:02:10 PM ET
    $ENFY
    Agricultural Chemicals
    Industrials

    $ENFY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enlightify Inc. Announces Delisting From NYSE

    XI'AN, CHINA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Enlightify Inc. (NYSE:ENFY) ("Enlightify" or the "Company"), today announced that it has received notification from the New York Stock Exchange ("NYSE") on October 13, 2025, that the NYSE has determined to commence proceedings to delist the Company's common stock from the exchange. The NYSE determined that the Company was no longer in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual, which requires listed companies to maintain an average global market capitalization average global market capitalization over a consecutive 30 trading day period of at least $15,000,000. The Company

    10/27/25 5:00:00 PM ET
    $CGA
    $ENFY
    Agricultural Chemicals
    Industrials

    Enlightify Inc. Notifies New York Stock Exchange of Intent to Cure Price Deficiency

    XI'AN, CHINA, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Enlightify Inc. (NYSE:ENFY) ("Enlightify" or the "Company") has notified the New York Stock Exchange ("NYSE") that it intends to cure the price deficiency that resulted from the fact that the 30-trading-day average closing price per share of the Company's common stock was below $1.00, which is the minimum average share price required for continued listing under NYSE rules. Under NYSE rules, the Company has six months (subject to possible extension) to regain compliance with this continued listing standard and avoid delisting.  The Company's common stock continues to be listed and traded on the NYSE, subject to the Company's compliance wi

    9/10/25 5:00:00 PM ET
    $CGA
    $ENFY
    Agricultural Chemicals
    Industrials

    Enlightify Inc. Receives Continued Listing Standards Notice from the New York Stock Exchange

    XI'AN, CHINA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- On August 27, 2025, Enlightify Inc. (NYSE:ENFY) ("Enlightify" or the "Company") was notified by the New York Stock Exchange ("NYSE") that the 30-trading-day average closing price per share of the Company's common stock was below $1.00, which is the minimum average share price required for continued listing under NYSE rules. As required by NYSE rules, no later than September 11, 2025, the Company will notify the NYSE of its intent to cure the share price deficiency and to return to compliance with this continued listing standard. Under NYSE rules, the Company has six months (subject to possible extension) to regain compliance with this cont

    9/2/25 5:00:00 PM ET
    $CGA
    $ENFY
    Agricultural Chemicals
    Industrials